Subcutaneous IGF-1 is not beneficial in 2-year ALS trial (Q24651555)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Subcutaneous IGF-1 is not beneficial in 2-year ALS trial |
scientific article |
Statements
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial (English)
0 references
25 November 2008
0 references
71
0 references
22
0 references
1770-5
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference